Business Description
Bioasis Technologies Inc
NAICS : 325410
SIC : 3741
ISIN : CA09064N1033
Compare
Compare
Traded in other countries / regions
BIOAF.USA IPO Date
2009-04-15Description
Bioasis Technologies Inc is a development stage biopharmaceutical company engaged in the research and development of products for the diagnosis and treatment of neurological diseases and disorders. The company's xB3 program describes its proprietary carrier, p97, and components thereof, to deliver therapeutics across the blood-brain barrier (BBB).
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
6-1 Month Momentum % | -50 | |||||
12-1 Month Momentum % | -50 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
FCF Margin % | -733.33 | |||||
OCF Margin % | -733.33 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History |
|---|
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:BIOAF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Bioasis Technologies Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.204 | ||
| EPS (TTM) ($) | -0.025 | ||
| Beta | 357.8354 | ||
| 3-Year Sharpe Ratio | 0.46 | ||
| 3-Year Sortino Ratio | 0.77 | ||
| Volatility % | 50 | ||
| 14-Day RSI | - | ||
| 14-Day ATR ($) | 0.000007 | ||
| 20-Day SMA ($) | 0.0001 | ||
| 12-1 Month Momentum % | -50 | ||
| 52-Week Range ($) | 0.0001 - 0.0002 | ||
| Shares Outstanding (Mil) | 79.41 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Bioasis Technologies Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Bioasis Technologies Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Bioasis Technologies Inc Frequently Asked Questions
What is Bioasis Technologies Inc(BIOAF)'s stock price today?
The current price of BIOAF is $0.00. The 52 week high of BIOAF is $0.00 and 52 week low is $0.00.
When is next earnings date of Bioasis Technologies Inc(BIOAF)?
The next earnings date of Bioasis Technologies Inc(BIOAF) is .
Does Bioasis Technologies Inc(BIOAF) pay dividends? If so, how much?
Bioasis Technologies Inc(BIOAF) does not pay dividend.
Guru Commentaries on OTCPK:BIOAF
No articles.
Press Release
| Subject | Date | ||
|---|---|---|---|
| Bioasis to Present at the OTC Markets 2020 Virtual Investor Conference | 2020-02-19 |
Articles on Bioasis Technologies Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers